Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
Is a |
Ethinylestradiol 30mcg+progestogen |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hormone |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethinylestradiol |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Progesterone |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Estradiol |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Synthetic progestogen (substance) |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
Has manufactured dose form |
Oral tablet |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
Is a |
Product containing estradiol in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
Is a |
Product containing ethinylestradiol and gestodene (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Gestodene (substance) |
false |
Inferred relationship |
Some |
|
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
Is a |
contraceptif oral combiné |
false |
Inferred relationship |
Some |
|
|